GENEVA, May 11 -- HONGYUN BIOTECH CO., LTD. (Room 410, Building 6, No.2 Xiejiashe Road, China Medical CityTaizhou, Jiangsu 225316), 泰州红云制药有限公司 (中国江苏省泰州市医药高新技术产业开发区解家舍路2号6号楼410室) filed a patent application (PCT/CN2024/129421) for "SUBSTITUTED QUINAZOLINE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMBINATION THEREOF, AND USE THEREOF" on Nov 01, 2024. With publication no. WO/2025/092989, the details related to the patent application was published on May 08, 2025.
Notably, the ...